Michael Eric Lisjak - 03 Jun 2024 Form 4 Insider Report for Cyclo Therapeutics, Inc. (CYTH)

Role
Chief Regulatory Officer
Signature
/s/ Michael Lisjak
Issuer symbol
CYTH
Transactions as of
03 Jun 2024
Net transactions value
$0
Form type
4
Filing time
05 Jun 2024, 17:11:38 UTC
Previous filing
09 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTH Stock Option (Right to Buy) Award $0 +110,732 $0.000000 110,732 03 Jun 2024 Common Stock 110,732 $1.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests over a one year period in equal quarterly installments.